We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
-1.17%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$332M
AUM Growth
-$10.4M
Cap. Flow
-$4.05M
Cap. Flow %
-1.22%
Top 10 Hldgs %
28.79%
Holding
176
New
1
Increased
39
Reduced
56
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Healthcare 16.29%
3 Consumer Staples 14.88%
4 Financials 13.56%
5 Energy 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLUE
126
DELISTED
bluebird bio
BLUE
$337K 0.1%
154
PAA icon
127
Plains All American Pipeline
PAA
$17.3B
$328K 0.1%
7,533
-962
-11% -$46.1K
BHP icon
128
BHP
BHP
$215B
$326K 0.1%
8,979
-435
-5% -$17.6K
SNY icon
129
Sanofi
SNY
$103B
$301K 0.09%
6,073
ADSK icon
130
Autodesk
ADSK
$49.5B
$300K 0.09%
6,000
SE
131
DELISTED
Spectra Energy Corp Wi
SE
$295K 0.09%
9,050
CVS icon
132
CVS Health
CVS
$133B
$289K 0.09%
2,755
+1,025
+59% +$105K
WMB icon
133
Williams Companies
WMB
$87.5B
$283K 0.09%
4,935
MET icon
134
MetLife
MET
$61.9B
$280K 0.08%
5,610
ITW icon
135
Illinois Tool Works
ITW
$82.6B
$278K 0.08%
3,030
BNY
136
Bank of New York Mellon
BNY
$106B
$275K 0.08%
6,553
INTU icon
137
Intuit
INTU
$86.5B
$274K 0.08%
2,720
+100
+4% +$10.2K
BMRN icon
138
BioMarin Pharmaceuticals
BMRN
$11.6B
$273K 0.08%
1,996
-214
-10% -$26.5K
PRE
139
DELISTED
PARTNERRE LTD
PRE
$270K 0.08%
2,100
K
140
DELISTED
Kellanova
K
$259K 0.08%
4,401
REGN icon
141
Regeneron Pharmaceuticals
REGN
$78.5B
$255K 0.08%
500
TROW icon
142
T. Rowe Price
TROW
$23.9B
$254K 0.08%
3,270
PAGP icon
143
Plains GP Holdings
PAGP
$5.21B
$252K 0.08%
3,661
MNDT
144
DELISTED
Mandiant, Inc. Common Stock
MNDT
$245K 0.07%
+5,000
New +$226K
ETP
145
DELISTED
Energy Transfer Partners, L.P.
ETP
$245K 0.07%
6,450
ANDX
146
DELISTED
Andeavor Logistics LP
ANDX
$243K 0.07%
4,250
GEL icon
147
Genesis Energy
GEL
$1.87B
$239K 0.07%
5,450
OKE icon
148
Oneok
OKE
$57.2B
$227K 0.07%
5,750
AGN
149
DELISTED
Allergan plc
AGN
$227K 0.07%
747
-357
-32% -$106K
EQM
150
DELISTED
EQM Midstream Partners, LP
EQM
$224K 0.07%
2,750

Similar funds

Fairfield, Bush & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Fairfield, Bush & Co held 176 positions worth $332M, down 3% from $343M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fairfield, Bush & Co's Q2 2015 filing shows 1 new, 39 increased, 56 reduced and 9 closed positions. Its largest new stake was Mandiant, Inc. Common Stock: 5,000 shares worth $245K. The largest sale was International Flavors & Fragrances, an estimated $3.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Fairfield, Bush & Co's largest Q2 2015 buy was Mandiant, Inc. Common Stock: 5,000 shares worth $245K.
  • Fairfield, Bush & Co added most to Energy Transfer Partners L.p. in Q2 2015, an estimated $2.17M increase.
  • Fairfield, Bush & Co's biggest Q2 2015 reduction was International Flavors & Fragrances, cutting an estimated $3.3M.
  • Fairfield, Bush & Co fully exited Concord Medical Services in Q2 2015, selling an estimated $612K.
  • Fairfield, Bush & Co's ten largest holdings make up 29% of its $332M portfolio in Q2 2015.
  • Fairfield, Bush & Co opened 1 new position and closed 9 in Q2 2015.
  • Fairfield, Bush & Co's portfolio value fell 3% quarter-over-quarter to $332M.

Based on Fairfield, Bush & Co's 13F filing for Q2 2015, filed 14 Aug 2015.